Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-023973
Filing Date
2021-09-28
Accepted
2021-09-28 15:53:07
Documents
72
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2799067
2 image_001.jpg GRAPHIC 69549
3 ex21-1.htm EX-21.1 3166
4 ex31-1.htm EX-31.1 11519
5 ex32-1.htm EX-32.1 8247
  Complete submission text file 0001493152-21-023973.txt   11753389

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ppcb-20210630.xsd EX-101.SCH 76332
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ppcb-20210630_cal.xml EX-101.CAL 73800
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ppcb-20210630_def.xml EX-101.DEF 312056
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ppcb-20210630_lab.xml EX-101.LAB 591280
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ppcb-20210630_pre.xml EX-101.PRE 432011
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1807522
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-54878 | Film No.: 211286673
SIC: 2834 Pharmaceutical Preparations